| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Theriva Biologics, Inc. | Director | Stock Options (right to buy) | 75,000 | 05 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TOVX | Theriva Biologics, Inc. | 05 Jan 2026 | 1 | $0 | 4 | Director | 06 Jan 2026, 16:53 |
| TOVX | Theriva Biologics, Inc. | 29 Apr 2025 | 1 | $0 | 4 | Director | 01 May 2025, 16:01 |
| TOVX | Theriva Biologics, Inc. | 14 Dec 2023 | 1 | $0 | 4 | Director | 15 Dec 2023, 16:00 |
| TOVX | Theriva Biologics, Inc. | 15 Dec 2022 | 1 | $0 | 4 | Director | 16 Dec 2022, 17:17 |
| TOVX | Synthetic Biologics, Inc. | 23 Dec 2021 | 1 | $0 | 4 | Director | 27 Dec 2021, 16:03 |